Evidence Regarding Pharmacogenetics in Pain Management and Cancer.
Citation: Oncologist. 2023 Jan 30PMID: 36718020Department: MedStar Health | PharmacogenomicsForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2023ISSN:- 1083-7159
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 36718020 | Available | 36718020 |
Patients experience interindividual variation in response to analgesics, which may be partially explained by genetics. This commentary discusses a recently published trial on COMT genotype and opioid dose requirements and describes the potential role for COMT and other genes (eg, CYP2D6) on opioid therapy and the current evidence for germline pharmacogenetics and resources for opioid pharmacogenetics. Copyright © The Author(s) 2023. Published by Oxford University Press.
English